Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1030)	3/24/2002 11:23:38 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 2243

DRUG DELIVERY ELAN PHARMACEUTICALS TECHNOLOGIES Products KEY MARKETED PRODUCTS Product Licencee Compound Indication Rapamune AHP Rapamycin Immunosuppressant Cardizem™ CD Aventis S.A. Diltiazem Hypertension and angina Verelan™ and Verelan PM Schwarz Pharma, Inc. Verapamil Hypertension Herbesser™ Tanabe Seiyaku Company Ltd. Diltiazem Hypertension and angina Nifedipine 30mg Biovail Corporation Nifedipine Hypertension Nicotine Transdermal Perrigo Company Nicotine Smoking cessation Ketoprofen Watson Pharmaceuticals, Inc. Ketoprofen Pain and arthritis Theodur™ Mitsubishi-Tokyo Pharmaceuticals, Inc. Theophylline Asthma and chronic bronchitis KEY RESEARCH AND DEVELOPMENT PRODUCT PIPELINE Product Partner Status Indication Morphelan™ Ligand Pharmaceuticals Incorporated NDA filed Chronic pain Undisclosed Novartis Pharmaceuticals Corporation NDA filed Undisclosed Luvox™ Solvay Pharmaceuticals, Inc. NDA filed Obsessive compulsive disorder, depression Nifedipine 60mg Biovail Corporation ANDAfiled Hypertension Undisclosed Merck &Co., Inc. Phase III Undisclosed Fampridine Acorda Therapeutics, Inc. Phase II MSand spinal cord injury Undisclosed AHP Phase II Undisclosed Undisclosed Janssen Pharmaceutica, N.V. Phase II Undisclosed Undisclosed Merck &Co., Inc. Phase II Undisclosed